| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/23/1985 | US4512970 Chemorecruitins of leukocytes and inflamed tissues |
| 04/23/1985 | US4512923 Luteinizing and follicle stimulating hormones and process for the preparation thereof |
| 04/17/1985 | EP0137746A2 Nitrogen substituted angiotensin converting enzyme inhibitors |
| 04/17/1985 | EP0137691A1 Production of immune interferon and its mRNA |
| 04/17/1985 | EP0137689A1 GRF analogs |
| 04/17/1985 | EP0137633A1 Method of expressing alpha-1-antitrypsin in bacteria and its use in therapeutic formulations, and vectors and bacteria for such method and their production |
| 04/17/1985 | EP0137457A2 Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
| 04/17/1985 | EP0137361A2 Insulin derivatives modified in position B 30, process for their preparation, their vuse and pharmaceutical agents for the treatment of diabetes mellitus |
| 04/17/1985 | EP0137339A1 Pharmacologically active peptides |
| 04/17/1985 | EP0137294A2 Gonadoliberin and gonadoliberin agonists in the treatment of metabolic diseases due to too small a parathormone level |
| 04/17/1985 | EP0137234A2 Physiologically active compositions |
| 04/16/1985 | US4511653 Process for the industrial preparation of collagenous materials from human placental tissues, human collagenous materials obtained and their application as biomaterials |
| 04/16/1985 | US4511558 Alpha-lactalbumin contraceptive |
| 04/16/1985 | US4511557 Calf's blood diaysate as vasodilation potentiator |
| 04/16/1985 | US4511556 Inactivation of a lipid virus |
| 04/16/1985 | US4511504 Collagenase inhibitors |
| 04/11/1985 | WO1985001515A1 T-cell growth factor of the gibbon ape |
| 04/11/1985 | WO1985001503A1 Superoxide dismutase cloning and expression in microorganisms |
| 04/11/1985 | WO1985001441A1 Preparation for rehydrating monogastric animals, including human beings, suffering from diarrhoea and use thereof |
| 04/11/1985 | EP0082184A4 Nutritional composition for management of hepatic failure. |
| 04/10/1985 | EP0136947A2 Conjugated lipopolysaccharides, process for their preparation and their use as immunizing agents |
| 04/10/1985 | EP0136938A2 Derivatives of furanes, their preparation and application |
| 04/10/1985 | EP0136835A2 Process for the preparation of antibody compositions of therapeutic agents having an extended serum half-life |
| 04/10/1985 | EP0136792A2 Neocarzinostatin derivatives and a process for manufacturing the same |
| 04/10/1985 | EP0136791A2 Neocarzinostatin derivatives and method of producing the same |
| 04/10/1985 | EP0136781A2 Treatment of endometriosis |
| 04/10/1985 | EP0136694A2 Production of monomeric human gamma-interferon |
| 04/10/1985 | EP0136620A1 Homogeneous immune interferon fragment |
| 04/10/1985 | EP0136475A2 Novel growth hormone-releasing peptides and method of treating mammals therewith |
| 04/10/1985 | EP0136472A1 Production of secretin |
| 04/10/1985 | EP0136375A1 A regulatory glycoprotein for immune response in the production of T-cell growth factor |
| 04/10/1985 | EP0136334A1 Method for producing very pure albumin and for depyrogenating albumin-containing starting substances |
| 04/10/1985 | EP0020780B1 Fibrinolytic material and process for producing same |
| 04/09/1985 | US4510322 Indacrinone having enhanced uricosuric |
| 04/09/1985 | US4510132 Compounds for use in antibacterial therapy |
| 04/09/1985 | US4510131 Purified Mullerian Inhibiting Substance and method of use |
| 04/09/1985 | US4510129 Mixture of antigen and neuraminidase |
| 04/09/1985 | US4510084 Using plasma to form complex, adsorptton on ion exchanger, separation, and lyophilization |
| 04/09/1985 | US4510082 Nonhabit-forming analgesics |
| 04/09/1985 | US4509836 Multi format shutterless motion picture inspection projector |
| 04/09/1985 | CA1185235A1 Antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin |
| 04/09/1985 | CA1185180A1 Peptides as medicament and certain novel peptides |
| 04/09/1985 | CA1185178A1 Method for purifying interferon |
| 04/03/1985 | EP0136093A2 Anti-cancer factors |
| 04/03/1985 | EP0136053A2 Preparation of proliferation inhibitors |
| 04/03/1985 | EP0135797A2 Process for preparing lymphotoxin and lymphotoxin-mRNA |
| 04/03/1985 | EP0135788A1 Muramyldipeptide active ester derivatives |
| 04/03/1985 | EP0135722A2 Peptides having an immunostimulating effect, process for their preparation and their use |
| 04/03/1985 | EP0135720A2 Process for the preparation of insuline derivatives |
| 04/03/1985 | EP0135592A1 Dna synthesis-repressing substance |
| 04/03/1985 | EP0135536A1 Anti-idiotypic antibodies to t cell antigen receptors |
| 04/02/1985 | US4508833 Separation of interleukin-2 from phytohemagglutinin by dye matrix chromatography |
| 04/02/1985 | US4508729 Hypotensive agents |
| 04/02/1985 | US4508727 Antihypertensive 2-oxo-imidazolidine derivatives |
| 04/02/1985 | US4508712 Atrial peptide |
| 04/02/1985 | US4508709 Adsorption, elution form aminohexyl agarose |
| 04/02/1985 | US4508645 Analogs of neurohypophysial hormones with inhibition effects |
| 04/02/1985 | CA1184899A1 Glycoprotein |
| 04/02/1985 | CA1184862A1 Filtration method for cell produced antiviral substances |
| 03/28/1985 | WO1985001292A1 Pharmacologically active peptides |
| 03/28/1985 | WO1985001284A1 Synthetic peptides with egf like activity and pharmaceutical compositions and methods of use |
| 03/27/1985 | EP0135410A1 Synergistin derivatives, their preparation and pharmaceutical compositions containing them |
| 03/27/1985 | EP0135379A2 Basic hexa- and hepta-peptide vasopressin antagonists |
| 03/27/1985 | EP0135352A2 Reagent for use in detecting antibody to human T-cell leukaemia virus antigen |
| 03/27/1985 | EP0135349A1 Condensed seven-membered ring compounds and their production and use |
| 03/27/1985 | EP0135312A2 Anti-viral compositions |
| 03/27/1985 | EP0135277A1 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same |
| 03/27/1985 | EP0135182A2 Process for the production of N-alkylated dipeptides and of their esters |
| 03/27/1985 | EP0135181A2 Process for the production of N-alkylated dipeptides and of their esters |
| 03/27/1985 | EP0135171A2 Pharmaceutical composition for interferon application |
| 03/27/1985 | EP0135094A1 Microbial expression of insulin-like growth factor |
| 03/27/1985 | EP0134986A2 Biologically active heptapeptides, agents thereof and their use |
| 03/27/1985 | EP0134923A2 Process for preparing a human endogenous cancer regulatory factor, pharmaceutical composition containing the same, and human monocytic leukemia cell lines |
| 03/27/1985 | EP0134803A1 Monoclonal antibody |
| 03/26/1985 | US4507283 Streptokinase-human plasminogen activator complex blocked by a 2- or 4-aminobenzoyl group; anticoagulant |
| 03/26/1985 | US4507282 Peptide antibiotics; anticarcinogenic agents |
| 03/26/1985 | US4507281 Interferon-containing compositions |
| 03/26/1985 | US4507277 Composition and method for stimulating the synthesis of the melanotic pigment of the skin |
| 03/26/1985 | US4507235 Method for preparing peptides and intermediate products |
| 03/26/1985 | US4507232 Peptide derivatives |
| 03/26/1985 | CA1184518A1 Reversible microencapsulation |
| 03/26/1985 | CA1184499A1 Nutritional composition for management of hepatic failure |
| 03/20/1985 | EP0134729A1 Process for the preparation of globin from hemoglobin, and globin obtained in this process |
| 03/20/1985 | EP0134631A1 Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
| 03/20/1985 | EP0134563A1 Novel aminoglycoside compounds and their acid addition salts and process for production thereof |
| 03/20/1985 | EP0134479A1 Modified proteinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 03/20/1985 | EP0134385A2 A protein having cell growth stimulating action, composition thereof and method for producing the same |
| 03/20/1985 | EP0134320A1 Conjugates of proteins with anti-tumour agents |
| 03/20/1985 | EP0134318A2 Controlled release of injectable and implantable insulin compositions |
| 03/20/1985 | EP0134247A1 Protein with oncostatic effect, process for its preparation, and oncostatic drug containing it |
| 03/19/1985 | US4505897 Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith |
| 03/19/1985 | US4505893 From cultured human tissues |
| 03/19/1985 | US4505854 Optically active dipeptides and the use thereof as tissue dissolving and histolytic agent in human beings |
| 03/19/1985 | US4505853 Enzyme-resistant immunomodulatory peptides |
| 03/19/1985 | US4505822 Process for separating substances from one another using a fibrin gel filter |
| 03/19/1985 | US4505817 Fibrin gel-containing filter of porous material |
| 03/19/1985 | CA1184138A1 Process for producing a vasal fibrinolytic active principle, and the enzymatic product so prepared |
| 03/14/1985 | WO1985001067A1 Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof |
| 03/14/1985 | WO1985000974A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 03/14/1985 | WO1984004249A3 Composition having an improved pharmaceutical activity and utilisation thereof in veterinary medecine |